Cargando…
miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis
BACKGROUND: Our previous work showed that some Rho GTPases, including Rho, Rac1 and Cdc42, play critical roles in gastric cancer (GC); however, how they are regulated in GC remains largely unknown. In this study, we aimed to investigate the roles and molecular mechanisms of Dock6, an atypical Rho gu...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872400/ https://www.ncbi.nlm.nih.gov/pubmed/29587866 http://dx.doi.org/10.1186/s13046-018-0729-z |
_version_ | 1783309828427350016 |
---|---|
author | Li, Xiaowei Jiang, Mingzuo Chen, Di Xu, Bing Wang, Rui Chu, Yi Wang, Weijie Zhou, Lin Lei, Zhijie Nie, Yongzhan Fan, Daiming Shang, Yulong Wu, Kaichun Liang, Jie |
author_facet | Li, Xiaowei Jiang, Mingzuo Chen, Di Xu, Bing Wang, Rui Chu, Yi Wang, Weijie Zhou, Lin Lei, Zhijie Nie, Yongzhan Fan, Daiming Shang, Yulong Wu, Kaichun Liang, Jie |
author_sort | Li, Xiaowei |
collection | PubMed |
description | BACKGROUND: Our previous work showed that some Rho GTPases, including Rho, Rac1 and Cdc42, play critical roles in gastric cancer (GC); however, how they are regulated in GC remains largely unknown. In this study, we aimed to investigate the roles and molecular mechanisms of Dock6, an atypical Rho guanine nucleotide exchange factor (GEF), in GC metastasis. METHODS: The expression levels of Dock6 and miR-148b-3p in GC tissues and paired nontumor tissues were determined by immunohistochemistry (IHC) and in situ hybridization (ISH), respectively. The correlation between Dock6/miR-148b-3p expression and the overall survival of GC patients was calculated by the Kaplan-Meier method and log-rank test. The roles of Dock6 and miR-148b-3p in GC were investigated by in vitro and in vivo functional studies. Rac1 and Cdc42 activation was investigated by GST pull-down assays. The inhibition of Dock6 transcription by miR-148b-3p was determined by luciferase reporter assays. RESULTS: A significant increase in Dock6 expression was found in GC tissues compared with nontumor tissues, and its positive expression was associated with lymph node metastasis and a higher TNM stage. Patients with positive Dock6 expression exhibited shorter overall survival periods than patients with negative Dock6 expression. Dock6 promoted GC migration and invasion by increasing the activation of Rac1 and Cdc42. miR-148b-3p expression was negatively correlated with Dock6 expression in GC, and it decreased the motility of GC cells by inhibiting the Dock6/Rac1/Cdc42 axis. CONCLUSIONS: Dock6 was over-expressed in GC tissues, and its positive expression was associated with GC metastasis and indicated poor prognosis of GC patients. Targeting of Dock6 by miR-148b-3p could activate Rac1 and Cdc42, directly affecting the motility of GC cells. Targeting the Dock6-Rac1/Cdc42 axis could serve as a new therapeutic strategy for GC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0729-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5872400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58724002018-04-02 miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis Li, Xiaowei Jiang, Mingzuo Chen, Di Xu, Bing Wang, Rui Chu, Yi Wang, Weijie Zhou, Lin Lei, Zhijie Nie, Yongzhan Fan, Daiming Shang, Yulong Wu, Kaichun Liang, Jie J Exp Clin Cancer Res Research BACKGROUND: Our previous work showed that some Rho GTPases, including Rho, Rac1 and Cdc42, play critical roles in gastric cancer (GC); however, how they are regulated in GC remains largely unknown. In this study, we aimed to investigate the roles and molecular mechanisms of Dock6, an atypical Rho guanine nucleotide exchange factor (GEF), in GC metastasis. METHODS: The expression levels of Dock6 and miR-148b-3p in GC tissues and paired nontumor tissues were determined by immunohistochemistry (IHC) and in situ hybridization (ISH), respectively. The correlation between Dock6/miR-148b-3p expression and the overall survival of GC patients was calculated by the Kaplan-Meier method and log-rank test. The roles of Dock6 and miR-148b-3p in GC were investigated by in vitro and in vivo functional studies. Rac1 and Cdc42 activation was investigated by GST pull-down assays. The inhibition of Dock6 transcription by miR-148b-3p was determined by luciferase reporter assays. RESULTS: A significant increase in Dock6 expression was found in GC tissues compared with nontumor tissues, and its positive expression was associated with lymph node metastasis and a higher TNM stage. Patients with positive Dock6 expression exhibited shorter overall survival periods than patients with negative Dock6 expression. Dock6 promoted GC migration and invasion by increasing the activation of Rac1 and Cdc42. miR-148b-3p expression was negatively correlated with Dock6 expression in GC, and it decreased the motility of GC cells by inhibiting the Dock6/Rac1/Cdc42 axis. CONCLUSIONS: Dock6 was over-expressed in GC tissues, and its positive expression was associated with GC metastasis and indicated poor prognosis of GC patients. Targeting of Dock6 by miR-148b-3p could activate Rac1 and Cdc42, directly affecting the motility of GC cells. Targeting the Dock6-Rac1/Cdc42 axis could serve as a new therapeutic strategy for GC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0729-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-27 /pmc/articles/PMC5872400/ /pubmed/29587866 http://dx.doi.org/10.1186/s13046-018-0729-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Xiaowei Jiang, Mingzuo Chen, Di Xu, Bing Wang, Rui Chu, Yi Wang, Weijie Zhou, Lin Lei, Zhijie Nie, Yongzhan Fan, Daiming Shang, Yulong Wu, Kaichun Liang, Jie miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis |
title | miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis |
title_full | miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis |
title_fullStr | miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis |
title_full_unstemmed | miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis |
title_short | miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis |
title_sort | mir-148b-3p inhibits gastric cancer metastasis by inhibiting the dock6/rac1/cdc42 axis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872400/ https://www.ncbi.nlm.nih.gov/pubmed/29587866 http://dx.doi.org/10.1186/s13046-018-0729-z |
work_keys_str_mv | AT lixiaowei mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT jiangmingzuo mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT chendi mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT xubing mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT wangrui mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT chuyi mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT wangweijie mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT zhoulin mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT leizhijie mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT nieyongzhan mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT fandaiming mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT shangyulong mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT wukaichun mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis AT liangjie mir148b3pinhibitsgastriccancermetastasisbyinhibitingthedock6rac1cdc42axis |